2. Prof. Roel Tolentino, MD, MBA, FPCS, FPSGS, FPSO, FMOSP, FACS (2013)
Memorial Sloan Kettering Cancer Center (NY, USA)
University Hospitals of Columbia University and Weill Cornell Medical College (NY, USA)
MD Anderson Cancer Center (Texas, USA)
Beijing Cancer Hospital (China)
Chongqing Medical University (China)
Suining Central Hospital (China)
Harvard Medical School (Mass., USA)
New Skills Academy (UK)
De La Salle University – BS. Biology; Medicine
Manila Med – General Surgery
SLMC – Surgical Oncology
Ateneo GSB - MBA
3. Former President – Phil. Soc. of Oncology
Chairman of Surgery – CEU School of Medicine
Professor IV – EAC Medicine
Training Officer, Dept. of Surgery – Amang RMMC
Former Training Officer – SLMC Surgical Oncology
42. 9/19/2020 42
more beneficial health behaviors
less symptoms
higher quality of life
more satisfied with treatment
Trust in their health care professional:
63. 9/19/2020 63
Non critically ill Covid-19 patients:
At risk for progressing to critical
illness
At risk for immune function and
muscle mass decline with poor
appetite
After recovery to further boost
the immune system
64. 9/19/2020 64
Recovering post Covid-19 ICU case
who are at:
High risk for dysphagia
Adequate nutrition and
hydration
Techniques to return to safe oral
feeding through textured foods
65. 9/19/2020 65
Non critically ill Covid-19 patients:
At risk for having gut dysbiosis
At risk for muscle mass decline
Possible GI symptoms
